Skip to content 
Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. It also develops Travelan (IMM-124E), which is in Phase II clinical trial, to reduce the risk of contracting travelers' diarrhea; and IMM-529, which is in Phase II clinical trial, for treating patients suffering from recurring clostridium difficile infection. In additon, the company develops IMM-986, that is in pre-clinical stage. Further, it offers technology platform. The company has a collaboration with the US Naval Medical Research Command and Silver Spring, MD, USA to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a research collaboration with the Walter Reed Army Institute of Research to develop three Shigella-specific therapeutic products. The company was formerly known as Anadis Limited and changed its name to Immuron Limited in December 2008. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia. more
| Time Frame | IMRN | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | -8.76% | -1.08% | -1.38% |
| 1-Month Return | -38.73% | -0.47% | -1.81% |
| 3-Month Return | -52.87% | 2.13% | 1.38% |
| 6-Month Return | -57.5% | 17.04% | 5.68% |
| 1-Year Return | -63.6% | 6.56% | 11.74% |
| 3-Year Return | -62.58% | 16.78% | 65.15% |
| 5-Year Return | -90.88% | 34.34% | 73.68% |
| 10-Year Return | -82.68% | 137.88% | 260.03% |
| Jun '21 | Jun '22 | Jun '23 | Jun '24 | Jun '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 145.78K | 765.19K | 1.80M | 4.90M | 7.29M | [{"date":"2021-06-30","value":2,"profit":true},{"date":"2022-06-30","value":10.5,"profit":true},{"date":"2023-06-30","value":24.77,"profit":true},{"date":"2024-06-30","value":67.28,"profit":true},{"date":"2025-06-30","value":100,"profit":true}] |
| Cost of Revenue | 810.84K | 241.69K | 64.63K | 1.57M | 2.52M | [{"date":"2021-06-30","value":32.15,"profit":true},{"date":"2022-06-30","value":9.58,"profit":true},{"date":"2023-06-30","value":2.56,"profit":true},{"date":"2024-06-30","value":62.1,"profit":true},{"date":"2025-06-30","value":100,"profit":true}] |
| Gross Profit | (665.06K) | 523.50K | 1.74M | 3.34M | 4.77M | [{"date":"2021-06-30","value":-13.96,"profit":false},{"date":"2022-06-30","value":10.99,"profit":true},{"date":"2023-06-30","value":36.52,"profit":true},{"date":"2024-06-30","value":70.03,"profit":true},{"date":"2025-06-30","value":100,"profit":true}] |
| Gross Margin | (456.22%) | 68.41% | 96.42% | 68.06% | 65.39% | [{"date":"2021-06-30","value":-473.16,"profit":false},{"date":"2022-06-30","value":70.96,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":70.59,"profit":true},{"date":"2025-06-30","value":67.82,"profit":true}] |
| Operating Expenses | 7.71M | 3.39M | 5.31M | 9.14M | 10.11M | [{"date":"2021-06-30","value":76.31,"profit":true},{"date":"2022-06-30","value":33.57,"profit":true},{"date":"2023-06-30","value":52.51,"profit":true},{"date":"2024-06-30","value":90.39,"profit":true},{"date":"2025-06-30","value":100,"profit":true}] |
| Operating Income | (8.38M) | (2.87M) | (3.57M) | (5.80M) | (5.34M) | [{"date":"2021-06-30","value":-837990800,"profit":false},{"date":"2022-06-30","value":-286985500,"profit":false},{"date":"2023-06-30","value":-356883800,"profit":false},{"date":"2024-06-30","value":-580111800,"profit":false},{"date":"2025-06-30","value":-534454800,"profit":false}] |
| Total Non-Operating Income/Expense | (9.11K) | 31.20K | (111.00K) | (815.66K) | 257.12K | [{"date":"2021-06-30","value":-3.54,"profit":false},{"date":"2022-06-30","value":12.14,"profit":true},{"date":"2023-06-30","value":-43.17,"profit":false},{"date":"2024-06-30","value":-317.23,"profit":false},{"date":"2025-06-30","value":100,"profit":true}] |
| Pre-Tax Income | (8.38M) | (2.85M) | (3.79M) | (6.94M) | (5.22M) | [{"date":"2021-06-30","value":-838446500,"profit":false},{"date":"2022-06-30","value":-285425400,"profit":false},{"date":"2023-06-30","value":-378650700,"profit":false},{"date":"2024-06-30","value":-693695700,"profit":false},{"date":"2025-06-30","value":-521598700,"profit":false}] |
| Income Taxes | (431.03K) | (257.50K) | (392.88K) | (764.98K) | - | [{"date":"2021-06-30","value":-43103000,"profit":false},{"date":"2022-06-30","value":-25750000,"profit":false},{"date":"2023-06-30","value":-39287700,"profit":false},{"date":"2024-06-30","value":-76498100,"profit":false},{"date":"2025-06-30","value":"-","profit":true}] |
| Income After Taxes | (7.95M) | (2.60M) | (3.39M) | (6.17M) | - | [{"date":"2021-06-30","value":-795343500,"profit":false},{"date":"2022-06-30","value":-259675400,"profit":false},{"date":"2023-06-30","value":-339363000,"profit":false},{"date":"2024-06-30","value":-617197600,"profit":false},{"date":"2025-06-30","value":"-","profit":true}] |
| Income From Continuous Operations | (8.38M) | (2.85M) | (3.79M) | (6.94M) | (5.22M) | [{"date":"2021-06-30","value":-838446500,"profit":false},{"date":"2022-06-30","value":-285425400,"profit":false},{"date":"2023-06-30","value":-378650700,"profit":false},{"date":"2024-06-30","value":-693695700,"profit":false},{"date":"2025-06-30","value":-521598700,"profit":false}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}] |
| Net Income | (8.38M) | (2.85M) | (3.79M) | (6.94M) | (5.22M) | [{"date":"2021-06-30","value":-838446500,"profit":false},{"date":"2022-06-30","value":-285425400,"profit":false},{"date":"2023-06-30","value":-378650700,"profit":false},{"date":"2024-06-30","value":-693695700,"profit":false},{"date":"2025-06-30","value":-521598700,"profit":false}] |
| EPS (Diluted) | (0.02) | - | - | - | (0.02) | [{"date":"2021-06-30","value":-1.9,"profit":false},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-06-30","value":-2,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
| IMRN | |
|---|---|
| Cash Ratio | 2.98 |
| Current Ratio | 5.07 |
| Quick Ratio | 4.17 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| IMRN | |
|---|---|
| ROA (LTM) | -26.08% |
| ROE (LTM) | -50.21% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| IMRN | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.20 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.80 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| IMRN | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.88 |
| P/B | 1.05 |
| Price/FCF | NM |
| EV/R | 0.86 |
| EV/Ebitda | 0.77 |
| PEG | NM |
Immuron Ltd ADR (IMRN) share price today is $0.7352
Yes, Indians can buy shares of Immuron Ltd ADR (IMRN) on Vested. To buy
Yes, you can purchase fractional shares of Immuron Ltd ADR (IMRN) via the Vested app. You can start investing in Immuron Ltd ADR (IMRN) with a minimum investment of $1.
You can invest in shares of Immuron Ltd ADR (IMRN) via Vested in three simple steps:
The 52-week high price of Immuron Ltd ADR (IMRN) is $2.39. The 52-week low price of Immuron Ltd ADR (IMRN) is $0.68.
The price-to-earnings (P/E) ratio of Immuron Ltd ADR (IMRN) is
The price-to-book (P/B) ratio of Immuron Ltd ADR (IMRN) is 1.05
The dividend yield of Immuron Ltd ADR (IMRN) is 0.00%
The market capitalization of Immuron Ltd ADR (IMRN) is $5.69M
The stock symbol (or ticker) of Immuron Ltd ADR is IMRN
Consider the share price of Immuron Ltd ADR as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Immuron Ltd ADR has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Immuron Ltd ADR shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Immuron Ltd ADR stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Immuron Ltd ADR and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Immuron Ltd ADR stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
